Sr. Director, Regulatory Affairs Third Rock Ventures LLCSr. Director, Regulatory AffairsCambridge, MA$245,000–$300,000 / yearThis individual will serve as a key cross-functional leader and regulatory expert, partnering closely with Program Leadership & Management, Clinical Development, Clinical Pharmacology, Clinical Operations, Biostatistics, Pharmacovigilance, CMC, Nonclinical, Quality, and Executive Leadership to advance innovative therapeutics through development and key regulatory milestones. We specifically target pathogenic antibodies and their cellular sources with bespoke Fc biotherapeutics engineered to selectively and completely eliminate the root causes of autoimmune and allergic diseases, and to achieve deep, durable responses while preserving essential immunity.
Sales Director Nucs AISales DirectorBoston, MassachusettsYou’ll own the full sales cycle across a wide range of deal sizes and customer types—from closing focused product deployments with independent imaging centers to securing large-scale enterprise agreements with pharmaceutical companies and hospital networks. Founded in 2024 by a multidisciplinary team of oncologists, AI researchers, and healthcare innovators, we’re tackling one of medicine’s most pressing challenges: the growing demand for accurate, timely cancer diagnostics in the face of rising scan volumes and limited radiologist capacity.
Lead Director - Software Development Engineering CVS Health CorpLead Director - Software Development EngineeringMA$144,200–$288,400 / yearWe are seeking an experienced Lead Director - Software Development Engineering, who will be accountable for building and executing the Solutions for Specialty Pharmacy focusing on Operational efficiency, value stream savings and roadmaps for multiyear forward looking technology strategy. CVS Health Specialty Pharmacy Engineering team is looking for a hands-on, passionate people leader who want to join a high energy and growing team to make a difference in customers' lives and who want to be on the forefront of digital innovation that aims to reinvent what a pharmacy and a health care company can be in the digital world.
Sr. Pathologist and Associate Medical Director Foundation Medicine IncSr. Pathologist and Associate Medical DirectorBoston, MA$272,000–$340,000 / yearThe role of Director, Molecular Pathology centralizes these responsibilities to one pathologist-supervision of molecular technologists (CAM and RTP); review of wet lab sequencing metrics and troubleshooting (CAM and RTP); supervision of bioinformatics case curation by computational biology operations (CBO) (CAM); ongoing reevaluation and updating of curation SOPs (CAM); ensuring adequate post-pipeline analysis training for members of CBO, TOCR, the MSL team, and pathology (CAM); collaboration with other FMI stakeholders (CAM and RTP); and final release of CGP results to patients and their physicians (CAM and RTP). In conjunction with the General Supervisors of the Molecular Lab Operations team, provide technical supervision of the Molecular Laboratory staff and testing: Review active and approve revisions to Molecular Lab SOPs & Work instructions in conjunction with QA, Regulatory, Lab Operations, and CLIA Laboratory Director to ensure high quality sequencing results.
Associate Director, Clinical Scientist Zenas BioPharma (USA) LLCAssociate Director, Clinical ScientistWaltham, MA$161,700–$202,200 / yearThis position works closely with Medical Directors to support medical monitoring activities, while partnering cross-functionally with Clinical Operations, Data Management, Biostatistics, Translational Sciences, Medical Affairs, and Regulatory Affairs to translate clinical strategy into operational deliverables and ensure rigorous ongoing review of trial data for quality, safety, and protocol compliance. Zenas' earlier stage programs include ZB021, a clinical-stage, potentially best-in-class, oral, IL-17AA/AF inhibitor; ZB022, a preclinical, potentially best-in-class, oral, brain-penetrant, TYK2 inhibitor; and ZB014, a preclinical half-life extended anti-CD-19 and FcRIIb monoclonal antibody.
Scientific Director Novo Nordisk ASScientific DirectorLexington, MA$200,000–$290,000 / yearWorking in close partnership with TA Leadership, Medical Directors, Clinical Trial Strategy Teams and cross-functional research partners, the Scientific Director influences key portfolio decisions and aligns biological rationale with therapeutic and development priorities. The role also requires cross-functional collaboration with R&D, External Innovation, Medical & Science, Translational Science, Computational Drug Discovery (CDD), Global Research Technologies (GRT) and R&D Strategy, as well as active participation in European and US-based consortia and academic partnerships.
New(Senior) Director, Drug Product CMC Centessa Pharmaceuticals, LLC(Senior) Director, Drug Product CMCBoston, MA$150,000–$225,000 / yearReporting to the Executive Director, CMC, this position will primarily lead work with external vendors and oversee nonclinical formulation development, with flexibility to support clinical drug product development, across programs to meet company deliverables and timelines. Work closely and collaboratively with cross-functional CMC groups including discovery, nonclinical, clinical, project management, legal, sourcing, supply chain, quality and regulatory, as well as other CMC functions.
Sr. Director, Assay Development Quanterix CorpSr. Director, Assay DevelopmentBillerica, MAEXPECTATIONS, COMPETENCIES, SKILLS & ABILITIES: Broad subject matter expertise in key technical aspects of commercial immunoassay development, including protein chemistry, antibody screening, antibody: bead conjugation, assay diluent formulation, multiplexing, preanalytical sample processing, scale-up, assay optimization, troubleshooting, multivariate data analysis, and analytical and clinical validation. Experience supporting regulated IVD products under EU IVDR and/or FDA frameworks, including design controls, analytical/clinical performance evidence, and partnering with RA/QA on technical documentation to enable CE marking, market access, and submission readiness.
Director, Information Technology ReplimuneDirector, Information TechnologyWoburn, Massachusetts$202,000–$261,500 / yearThe RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response. The ideal candidate combines strong leadership, strategic thinking, and operational execution, with experience building high-performing teams, managing vendor relationships, and delivering technology solutions in regulated environments.
Director, Medical Lead - CNS Azurity Pharmaceuticals - USDirector, Medical Lead - CNSWoburn, MARemoteAs an industry leader in providing unique, accessible, and high-quality medications, Azurity leverages its integrated capabilities and vast partner network to continually expand its broad commercial product portfolio and robust late-stage pipeline. The company's patient-centric products span the cardiovascular, neurology, endocrinology, gastro-intestinal, institutional, and orphan markets, and have benefited millions of patients.
Senior Director, Corporate Quality - PV Sarepta Therapeutics Inc.Senior Director, Corporate Quality - PVBedford, MA$222,400–$278,000 / yearThis position will liaise with internal groups such as Pharmacovigilance Operations, Safety Evaluation & Risk Management, and Market Research, as well as external groups including contract auditors in an effort to ensure a high level of quality and consistency across the Sarepta platform; design and oversee the audit strategy; assist the GVP team in identifying and implementing corrective and preventive actions; and enable teams to be inspection ready, in support of a culture of sustainable compliance. Primary responsibilities include: Participate in the development of the internal and external Corporate Quality annual audit plan for GVP, REMS, PV vendors, interfaces, processes and preferred business partners and update the audit plan as needed based on identified risks and priorities.
NewAssociate Director, Risk Based Quality Management, Oncology SunovionAssociate Director, Risk Based Quality Management, OncologyMarlborough, MA$164,600–$205,700 / yearThe role is responsible for providing study-level leadership for Risk Based Quality Management (RBQM) across Phase 1 to Phase 4 oncology clinical trials and works closely with Clinical Operations, Data Management, Biostatistics, Clinical Project Teams, Quality, and other partner functions to ensure proactive risk assessment, centralized monitoring, mitigation planning, inspection readiness, and aligned execution of SMPA RBQM strategy. This position reports to the Executive Director, Data Management, Oncology and is part of the Data Management Oncology organization, which supports high-quality clinical trial execution through data oversight, risk identification, documentation, analytics, and cross-functional study support.
Director, Multicultural Inclusive Marketing Madrigal Pharmaceuticals IncDirector, Multicultural Inclusive MarketingWaltham, MA$218,000–$266,000 / yearCollaborate in the acquisition of customer and market insights through established and new channels including advisory boards, focus groups, and primary market research to understand the needs, behaviors, and barriers of diverse populations (e.g., women with MASH and other co-morbidities, Hispanic/Latino, African American, Asian and other segments to be defined). This role will collaborate closely with key stakeholders in HCP and DTC marketing and other key Commercial/Medical partners to ensure that all initiatives are inclusive, authentic, and supportive of health equity and improved patient outcomes all while being aligned with brand strategy.
NewDirector, Bioanalytical MBX BiosciencesDirector, BioanalyticalBurlington, MAOur pipeline includes canvuparatide (MBX 2109) for the treatment of chronic hypoparathyroidism, currently preparing for Phase 3 development, and a growing obesity portfolio that includes MBX 4291 in Phase 1 development, MBX 5765, a next-generation amycretin prodrug designed for once-monthly-dosing, as well as MBX 6180, a GLP/GIP/GCGR triple agonist prodrug for once monthly dosing; all of which optimize our PEP platform. The Director of Bioanalytical Sciences at MBX Biosciences is expected to provide strategic, scientific, and operational leadership for the development, validation, and execution of bioanalytical strategies that support the company's portfolio of precision peptide therapeutics across discovery, preclinical, and clinical development stages.
Senior Director, Biotherapeutics Manifold BioSenior Director, BiotherapeuticsBoston, MA$240,000–$340,000 / yearThis role spans discovery and nonclinical development, including bioengineering strategies to generate best-in-class molecules and oversight of external contract manufacturing organizations (CDMOs) to develop processes and manufacture drug product for clinical trials. Manifold Bio is a platform biotechnology company pioneering AI-guided protein design and massively multiplexed in vivo screening to unlock tissue-targeted medicines and organism-scale models of living systems.
Associate Business Development Director Novo Nordisk ASAssociate Business Development DirectorCambridge, MA$180,000–$220,000 / yearLeads cross-functional evaluations of all aspects of therapeutic drug programs from preclinical through clinical stages across the relevant assessment areas: proposed clinical benefit, mechanism, preclinical data, manufacturing, regulatory strategy, clinical development path, intellectual property and commercial potential. Leads diligence teams effectively with search and evaluation, legal, finance, commercial, clinical and scientific teams to ensure all necessary inputs to make business development proposals to senior management.
NewSenior Director, Quality Compliance Kiniksa Pharmaceuticals CorpSenior Director, Quality ComplianceLexington, MA$250,000–$273,000 / yearThis role leads key quality systems including supplier oversight, product complaints, and inspection readiness, and partners cross-functionally to drive a proactive, risk-based quality culture that supports development through commercialization. We''re seeking a Senior Director, Quality Compliance reporting to the VP, Head of Quality, who will be responsible for providing strategic leadership and oversight of the organization's global quality compliance programs, ensuring alignment with regulatory requirements and industry best practices.
Clinical Audit Response Specialist Dana-Farber Cancer Institute IncClinical Audit Response SpecialistBOSTON, MARemoteReporting to the Director of Patient Financial Services, the Revenue Protection Specialist is responsible for managing and responding to external audits from government and commercial insurance companies, as well as interpreting evolving payer policies to safeguard the Institutes revenue. The Revenue Protection Specialist will utilize their clinical expertise and knowledge of billing practices to address audit findings, interpret payer policies, prepare detailed responses, and implement corrective actions to enhance compliance and revenue integrity.
Clinical Risk Liaison Dana-Farber Cancer Institute IncClinical Risk LiaisonBrookline, MA$120,100–$138,200 / yearThe Liaison is approved as a short-term position matrixed into the Transitional Management Office and other relevant governance structures to drive a systematic approach to identifying safety-related clinical, operational, regulatory, and technical vulnerabilities, with the goal of reducing preventable patient harm. Coordinates risk due diligence activities: conducts risk assessments, reviews policies and documents, escalates risks as needed to QPS leadership, and maintains the transition risk register, issues log, and heat maps.
Director National Accounts Intellia TherapeuticsDirector National AccountsCambridge, MA$243,000–$297,000 / yearPartner closely with Field Market Access, Trade, and Channel teams to co-develop and deliver integrated account strategies that enhance access, affordability, and distribution of gene therapy products across national payers, PBMs, IDNs, and specialty pharmacies. Partner with internal teams (Market Access Strategy, Contracts and Pricing, HEOR, Medical Affairs, Clinical, Regulatory) to develop and tailor payer-facing materials, including early scientific exchange, evidence dossiers, PIE presentations, and budget impact models.